nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—CYP2C9—brain cancer	0.545	1	CbGaD
Apixaban—CYP1A2—Carmustine—brain cancer	0.0605	0.183	CbGbCtD
Apixaban—ABCG2—Carboplatin—brain cancer	0.0518	0.157	CbGbCtD
Apixaban—CYP3A4—Temozolomide—brain cancer	0.0457	0.138	CbGbCtD
Apixaban—ABCG2—Etoposide—brain cancer	0.0435	0.132	CbGbCtD
Apixaban—CYP3A4—Lomustine—brain cancer	0.0389	0.118	CbGbCtD
Apixaban—CYP3A5—Etoposide—brain cancer	0.0241	0.0729	CbGbCtD
Apixaban—CYP2C8—Etoposide—brain cancer	0.0232	0.0701	CbGbCtD
Apixaban—CYP1A2—Etoposide—brain cancer	0.0179	0.0542	CbGbCtD
Apixaban—ABCB1—Etoposide—brain cancer	0.0157	0.0474	CbGbCtD
Apixaban—CYP3A4—Etoposide—brain cancer	0.0094	0.0284	CbGbCtD
Apixaban—CYP2J2—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00788	0.124	CbGpPWpGaD
Apixaban—CYP2J2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00709	0.112	CbGpPWpGaD
Apixaban—Retinal haemorrhage—Procarbazine—brain cancer	0.00354	0.0647	CcSEcCtD
Apixaban—CYP2J2—Xenobiotics—CYP2C9—brain cancer	0.0034	0.0536	CbGpPWpGaD
Apixaban—Retinal haemorrhage—Carmustine—brain cancer	0.00221	0.0405	CcSEcCtD
Apixaban—Contusion—Lomustine—brain cancer	0.00208	0.0381	CcSEcCtD
Apixaban—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00197	0.031	CbGpPWpGaD
Apixaban—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00177	0.0278	CbGpPWpGaD
Apixaban—Haemorrhage intracranial—Temozolomide—brain cancer	0.0017	0.0311	CcSEcCtD
Apixaban—Haematemesis—Procarbazine—brain cancer	0.00166	0.0303	CcSEcCtD
Apixaban—CYP2J2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00164	0.0257	CbGpPWpGaD
Apixaban—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00161	0.0253	CbGpPWpGaD
Apixaban—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00158	0.0249	CbGpPWpGaD
Apixaban—Haemoptysis—Procarbazine—brain cancer	0.00156	0.0285	CcSEcCtD
Apixaban—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00144	0.0226	CbGpPWpGaD
Apixaban—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00141	0.0223	CbGpPWpGaD
Apixaban—Petechiae—Procarbazine—brain cancer	0.0014	0.0256	CcSEcCtD
Apixaban—CYP2J2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00139	0.022	CbGpPWpGaD
Apixaban—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00137	0.0216	CbGpPWpGaD
Apixaban—Cerebral haemorrhage—Carmustine—brain cancer	0.0013	0.0238	CcSEcCtD
Apixaban—Cerebral haemorrhage—Temozolomide—brain cancer	0.00126	0.023	CcSEcCtD
Apixaban—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00123	0.0194	CbGpPWpGaD
Apixaban—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00122	0.0193	CbGpPWpGaD
Apixaban—Transaminases increased—Carmustine—brain cancer	0.00119	0.0217	CcSEcCtD
Apixaban—CYP2J2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00115	0.018	CbGpPWpGaD
Apixaban—Melaena—Procarbazine—brain cancer	0.00113	0.0206	CcSEcCtD
Apixaban—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00112	0.0176	CbGpPWpGaD
Apixaban—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000981	0.0154	CbGpPWpGaD
Apixaban—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000944	0.0149	CbGpPWpGaD
Apixaban—Vaginal haemorrhage—Temozolomide—brain cancer	0.000942	0.0172	CcSEcCtD
Apixaban—Menorrhagia—Temozolomide—brain cancer	0.000942	0.0172	CcSEcCtD
Apixaban—Haemoglobin—Lomustine—brain cancer	0.000917	0.0168	CcSEcCtD
Apixaban—Haemorrhage—Lomustine—brain cancer	0.000912	0.0167	CcSEcCtD
Apixaban—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.00085	0.0134	CbGpPWpGaD
Apixaban—Petechiae—Temozolomide—brain cancer	0.000847	0.0155	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.000847	0.0155	CcSEcCtD
Apixaban—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000817	0.0129	CbGpPWpGaD
Apixaban—CYP2J2—blood vessel—brain cancer	0.000789	0.127	CbGeAlD
Apixaban—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000759	0.0119	CbGpPWpGaD
Apixaban—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000729	0.0115	CbGpPWpGaD
Apixaban—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000674	0.0106	CbGpPWpGaD
Apixaban—Thrombocytopenia—Lomustine—brain cancer	0.000634	0.0116	CcSEcCtD
Apixaban—Haematuria—Procarbazine—brain cancer	0.000615	0.0112	CcSEcCtD
Apixaban—CYP2J2—Biological oxidations—CYP2C9—brain cancer	0.000609	0.00958	CbGpPWpGaD
Apixaban—Epistaxis—Procarbazine—brain cancer	0.000608	0.0111	CcSEcCtD
Apixaban—Diabetes mellitus—Carmustine—brain cancer	0.000602	0.011	CcSEcCtD
Apixaban—CYP2J2—Metapathway biotransformation—CYP2C9—brain cancer	0.0006	0.00945	CbGpPWpGaD
Apixaban—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000591	0.0093	CbGpPWpGaD
Apixaban—Breast disorder—Hydroxyurea—brain cancer	0.000585	0.0107	CcSEcCtD
Apixaban—Haemoglobin—Procarbazine—brain cancer	0.000582	0.0106	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.000582	0.0106	CcSEcCtD
Apixaban—Haemorrhage—Procarbazine—brain cancer	0.000579	0.0106	CcSEcCtD
Apixaban—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000568	0.00895	CbGpPWpGaD
Apixaban—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000524	0.00957	CcSEcCtD
Apixaban—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000521	0.0082	CbGpPWpGaD
Apixaban—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000508	0.008	CbGpPWpGaD
Apixaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000484	0.00762	CbGpPWpGaD
Apixaban—Liver function test abnormal—Carmustine—brain cancer	0.000483	0.00884	CcSEcCtD
Apixaban—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000483	0.0076	CbGpPWpGaD
Apixaban—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000472	0.00863	CcSEcCtD
Apixaban—Anaemia—Procarbazine—brain cancer	0.000466	0.00852	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000466	0.00851	CcSEcCtD
Apixaban—Breast disorder—Temozolomide—brain cancer	0.000457	0.00836	CcSEcCtD
Apixaban—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000456	0.00718	CbGpPWpGaD
Apixaban—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000456	0.00833	CcSEcCtD
Apixaban—Syncope—Procarbazine—brain cancer	0.000452	0.00827	CcSEcCtD
Apixaban—Haemoglobin—Hydroxyurea—brain cancer	0.00045	0.00824	CcSEcCtD
Apixaban—Haemorrhage—Hydroxyurea—brain cancer	0.000448	0.00819	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000446	0.00816	CcSEcCtD
Apixaban—Loss of consciousness—Procarbazine—brain cancer	0.000443	0.0081	CcSEcCtD
Apixaban—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000439	0.00691	CbGpPWpGaD
Apixaban—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000408	0.00643	CbGpPWpGaD
Apixaban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000407	0.00641	CbGpPWpGaD
Apixaban—Angiopathy—Hydroxyurea—brain cancer	0.000407	0.00743	CcSEcCtD
Apixaban—Shock—Procarbazine—brain cancer	0.000405	0.0074	CcSEcCtD
Apixaban—Thrombocytopenia—Procarbazine—brain cancer	0.000403	0.00736	CcSEcCtD
Apixaban—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000402	0.00633	CbGpPWpGaD
Apixaban—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000387	0.00609	CbGpPWpGaD
Apixaban—Nausea—Lomustine—brain cancer	0.000385	0.00704	CcSEcCtD
Apixaban—Hypotension—Procarbazine—brain cancer	0.000384	0.00703	CcSEcCtD
Apixaban—CYP2J2—telencephalon—brain cancer	0.000383	0.0618	CbGeAlD
Apixaban—Hepatobiliary disease—Temozolomide—brain cancer	0.000369	0.00674	CcSEcCtD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000366	0.00577	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000364	0.00574	CbGpPWpGaD
Apixaban—Haemoglobin—Carmustine—brain cancer	0.000364	0.00666	CcSEcCtD
Apixaban—Haemorrhage—Carmustine—brain cancer	0.000362	0.00662	CcSEcCtD
Apixaban—Anaemia—Hydroxyurea—brain cancer	0.000361	0.00659	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Etoposide—brain cancer	0.000357	0.00653	CcSEcCtD
Apixaban—Connective tissue disorder—Carmustine—brain cancer	0.000356	0.00651	CcSEcCtD
Apixaban—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000353	0.00556	CbGpPWpGaD
Apixaban—Haemoglobin—Temozolomide—brain cancer	0.000352	0.00643	CcSEcCtD
Apixaban—Haemorrhage—Temozolomide—brain cancer	0.00035	0.0064	CcSEcCtD
Apixaban—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000348	0.00548	CbGpPWpGaD
Apixaban—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000346	0.00545	CbGpPWpGaD
Apixaban—Urinary tract disorder—Temozolomide—brain cancer	0.000346	0.00632	CcSEcCtD
Apixaban—Connective tissue disorder—Temozolomide—brain cancer	0.000344	0.00629	CcSEcCtD
Apixaban—Urethral disorder—Temozolomide—brain cancer	0.000343	0.00627	CcSEcCtD
Apixaban—Eye disorder—Carmustine—brain cancer	0.000339	0.00619	CcSEcCtD
Apixaban—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000334	0.00525	CbGpPWpGaD
Apixaban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00033	0.0052	CbGpPWpGaD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00033	0.00603	CcSEcCtD
Apixaban—F10—Hemostasis—MPL—brain cancer	0.000328	0.00517	CbGpPWpGaD
Apixaban—Eye disorder—Temozolomide—brain cancer	0.000327	0.00598	CcSEcCtD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000327	0.00514	CbGpPWpGaD
Apixaban—Angiopathy—Temozolomide—brain cancer	0.000318	0.00581	CcSEcCtD
Apixaban—Immune system disorder—Temozolomide—brain cancer	0.000316	0.00578	CcSEcCtD
Apixaban—Mediastinal disorder—Temozolomide—brain cancer	0.000316	0.00577	CcSEcCtD
Apixaban—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000315	0.00496	CbGpPWpGaD
Apixaban—F10—Hemostasis—S100A10—brain cancer	0.000315	0.00495	CbGpPWpGaD
Apixaban—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000313	0.00493	CbGpPWpGaD
Apixaban—Nervous system disorder—Hydroxyurea—brain cancer	0.000312	0.00571	CcSEcCtD
Apixaban—Thrombocytopenia—Hydroxyurea—brain cancer	0.000312	0.0057	CcSEcCtD
Apixaban—CYP2J2—pituitary gland—brain cancer	0.000312	0.0503	CbGeAlD
Apixaban—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000311	0.00489	CbGpPWpGaD
Apixaban—Skin disorder—Hydroxyurea—brain cancer	0.000309	0.00565	CcSEcCtD
Apixaban—Hypersensitivity—Procarbazine—brain cancer	0.000303	0.00554	CcSEcCtD
Apixaban—CYP2J2—medulla oblongata—brain cancer	0.000301	0.0486	CbGeAlD
Apixaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000298	0.0047	CbGpPWpGaD
Apixaban—Hepatobiliary disease—Etoposide—brain cancer	0.000295	0.0054	CcSEcCtD
Apixaban—F10—endocrine gland—brain cancer	0.000294	0.0476	CbGeAlD
Apixaban—Anaemia—Carmustine—brain cancer	0.000291	0.00533	CcSEcCtD
Apixaban—F10—head—brain cancer	0.000291	0.047	CbGeAlD
Apixaban—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000286	0.0045	CbGpPWpGaD
Apixaban—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000284	0.00447	CbGpPWpGaD
Apixaban—Anaemia—Temozolomide—brain cancer	0.000282	0.00515	CcSEcCtD
Apixaban—Urinary tract disorder—Etoposide—brain cancer	0.000277	0.00506	CcSEcCtD
Apixaban—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000275	0.00503	CcSEcCtD
Apixaban—CYP2J2—midbrain—brain cancer	0.000275	0.0444	CbGeAlD
Apixaban—Urethral disorder—Etoposide—brain cancer	0.000275	0.00502	CcSEcCtD
Apixaban—Dizziness—Procarbazine—brain cancer	0.000272	0.00497	CcSEcCtD
Apixaban—CYP2J2—spinal cord—brain cancer	0.000268	0.0433	CbGeAlD
Apixaban—Eye disorder—Etoposide—brain cancer	0.000262	0.00479	CcSEcCtD
Apixaban—Rash—Procarbazine—brain cancer	0.000259	0.00474	CcSEcCtD
Apixaban—Dermatitis—Procarbazine—brain cancer	0.000259	0.00474	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000258	0.00471	CcSEcCtD
Apixaban—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000255	0.00402	CbGpPWpGaD
Apixaban—Angiopathy—Etoposide—brain cancer	0.000254	0.00465	CcSEcCtD
Apixaban—Immune system disorder—Etoposide—brain cancer	0.000253	0.00463	CcSEcCtD
Apixaban—Mediastinal disorder—Etoposide—brain cancer	0.000252	0.00462	CcSEcCtD
Apixaban—Thrombocytopenia—Carmustine—brain cancer	0.000252	0.00461	CcSEcCtD
Apixaban—Anaphylactic shock—Temozolomide—brain cancer	0.000249	0.00455	CcSEcCtD
Apixaban—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000245	0.00386	CbGpPWpGaD
Apixaban—Nausea—Procarbazine—brain cancer	0.000244	0.00447	CcSEcCtD
Apixaban—Nervous system disorder—Temozolomide—brain cancer	0.000244	0.00446	CcSEcCtD
Apixaban—Thrombocytopenia—Temozolomide—brain cancer	0.000244	0.00445	CcSEcCtD
Apixaban—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000242	0.00381	CbGpPWpGaD
Apixaban—Skin disorder—Temozolomide—brain cancer	0.000242	0.00442	CcSEcCtD
Apixaban—CYP2J2—endocrine gland—brain cancer	0.000241	0.039	CbGeAlD
Apixaban—Hypotension—Carmustine—brain cancer	0.00024	0.0044	CcSEcCtD
Apixaban—CYP2J2—head—brain cancer	0.000238	0.0385	CbGeAlD
Apixaban—Hypersensitivity—Hydroxyurea—brain cancer	0.000235	0.00429	CcSEcCtD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000234	0.00368	CbGpPWpGaD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000229	0.0036	CbGpPWpGaD
Apixaban—Anaemia—Etoposide—brain cancer	0.000225	0.00412	CcSEcCtD
Apixaban—Gastrointestinal disorder—Carmustine—brain cancer	0.000222	0.00406	CcSEcCtD
Apixaban—F10—Hemostasis—BSG—brain cancer	0.000222	0.00349	CbGpPWpGaD
Apixaban—CYP2J2—central nervous system—brain cancer	0.000217	0.0351	CbGeAlD
Apixaban—Gastrointestinal disorder—Temozolomide—brain cancer	0.000215	0.00393	CcSEcCtD
Apixaban—Loss of consciousness—Etoposide—brain cancer	0.000214	0.00392	CcSEcCtD
Apixaban—CYP2J2—cerebellum—brain cancer	0.000213	0.0344	CbGeAlD
Apixaban—Dizziness—Hydroxyurea—brain cancer	0.000211	0.00385	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000206	0.00377	CcSEcCtD
Apixaban—Rash—Hydroxyurea—brain cancer	0.000201	0.00367	CcSEcCtD
Apixaban—Dermatitis—Hydroxyurea—brain cancer	0.000201	0.00367	CcSEcCtD
Apixaban—Anaphylactic shock—Etoposide—brain cancer	0.000199	0.00364	CcSEcCtD
Apixaban—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000199	0.00313	CbGpPWpGaD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000198	0.00312	CbGpPWpGaD
Apixaban—Thrombocytopenia—Etoposide—brain cancer	0.000195	0.00356	CcSEcCtD
Apixaban—Skin disorder—Etoposide—brain cancer	0.000193	0.00353	CcSEcCtD
Apixaban—Hypersensitivity—Carmustine—brain cancer	0.00019	0.00347	CcSEcCtD
Apixaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000189	0.00298	CbGpPWpGaD
Apixaban—Nausea—Hydroxyurea—brain cancer	0.000189	0.00346	CcSEcCtD
Apixaban—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000187	0.00294	CbGpPWpGaD
Apixaban—Hypotension—Etoposide—brain cancer	0.000186	0.0034	CcSEcCtD
Apixaban—Hypersensitivity—Temozolomide—brain cancer	0.000183	0.00335	CcSEcCtD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000177	0.00278	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000175	0.00276	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000173	0.00272	CbGpPWpGaD
Apixaban—CYP2J2—brain—brain cancer	0.000173	0.0279	CbGeAlD
Apixaban—Gastrointestinal disorder—Etoposide—brain cancer	0.000172	0.00314	CcSEcCtD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000171	0.00269	CbGpPWpGaD
Apixaban—Dizziness—Carmustine—brain cancer	0.00017	0.00311	CcSEcCtD
Apixaban—Dizziness—Temozolomide—brain cancer	0.000164	0.00301	CcSEcCtD
Apixaban—Rash—Carmustine—brain cancer	0.000162	0.00297	CcSEcCtD
Apixaban—Dermatitis—Carmustine—brain cancer	0.000162	0.00296	CcSEcCtD
Apixaban—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000161	0.00253	CbGpPWpGaD
Apixaban—Rash—Temozolomide—brain cancer	0.000157	0.00287	CcSEcCtD
Apixaban—Dermatitis—Temozolomide—brain cancer	0.000157	0.00286	CcSEcCtD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000154	0.00242	CbGpPWpGaD
Apixaban—Nausea—Carmustine—brain cancer	0.000153	0.0028	CcSEcCtD
Apixaban—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000152	0.00239	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.00015	0.00236	CbGpPWpGaD
Apixaban—Nausea—Temozolomide—brain cancer	0.000148	0.0027	CcSEcCtD
Apixaban—ABCB1—blood vessel—brain cancer	0.000147	0.0238	CbGeAlD
Apixaban—Hypersensitivity—Etoposide—brain cancer	0.000147	0.00268	CcSEcCtD
Apixaban—F10—Hemostasis—TRPC6—brain cancer	0.000145	0.00229	CbGpPWpGaD
Apixaban—ABCG2—telencephalon—brain cancer	0.000145	0.0234	CbGeAlD
Apixaban—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000143	0.00225	CbGpPWpGaD
Apixaban—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000142	0.00224	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000136	0.00214	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000134	0.00211	CbGpPWpGaD
Apixaban—Dizziness—Etoposide—brain cancer	0.000132	0.00241	CcSEcCtD
Apixaban—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000131	0.00206	CbGpPWpGaD
Apixaban—Rash—Etoposide—brain cancer	0.000125	0.00229	CcSEcCtD
Apixaban—Dermatitis—Etoposide—brain cancer	0.000125	0.00229	CcSEcCtD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000124	0.00195	CbGpPWpGaD
Apixaban—CYP2C8—pituitary gland—brain cancer	0.000121	0.0196	CbGeAlD
Apixaban—Nausea—Etoposide—brain cancer	0.000118	0.00216	CcSEcCtD
Apixaban—ABCG2—pituitary gland—brain cancer	0.000118	0.0191	CbGeAlD
Apixaban—ABCG2—medulla oblongata—brain cancer	0.000114	0.0184	CbGeAlD
Apixaban—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	0.00011	0.00173	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000109	0.00172	CbGpPWpGaD
Apixaban—F10—Hemostasis—VAV1—brain cancer	0.000109	0.00171	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000108	0.0017	CbGpPWpGaD
Apixaban—CYP2C19—endocrine gland—brain cancer	0.000108	0.0174	CbGeAlD
Apixaban—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000106	0.00166	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000104	0.00164	CbGpPWpGaD
Apixaban—ABCG2—midbrain—brain cancer	0.000104	0.0168	CbGeAlD
Apixaban—CYP2J2—Metabolism—CYP2C9—brain cancer	0.000104	0.00164	CbGpPWpGaD
Apixaban—ABCG2—spinal cord—brain cancer	0.000102	0.0164	CbGeAlD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	9.75e-05	0.00154	CbGpPWpGaD
Apixaban—CYP2C8—endocrine gland—brain cancer	9.41e-05	0.0152	CbGeAlD
Apixaban—CYP2J2—Metabolism—BSG—brain cancer	8.85e-05	0.00139	CbGpPWpGaD
Apixaban—CYP1A2—endocrine gland—brain cancer	8.81e-05	0.0142	CbGeAlD
Apixaban—CYP3A5—endocrine gland—brain cancer	8.49e-05	0.0137	CbGeAlD
Apixaban—ABCB1—Allograft Rejection—PDGFRA—brain cancer	8.44e-05	0.00133	CbGpPWpGaD
Apixaban—CYP2C9—endocrine gland—brain cancer	8.36e-05	0.0135	CbGeAlD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	8.35e-05	0.00132	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.16e-05	0.00128	CbGpPWpGaD
Apixaban—ABCG2—cerebellum—brain cancer	8.06e-05	0.013	CbGeAlD
Apixaban—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	8.04e-05	0.00127	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—IDH1—brain cancer	7.61e-05	0.0012	CbGpPWpGaD
Apixaban—ABCB1—telencephalon—brain cancer	7.15e-05	0.0116	CbGeAlD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	7.04e-05	0.00111	CbGpPWpGaD
Apixaban—F10—Hemostasis—PIK3CG—brain cancer	6.92e-05	0.00109	CbGpPWpGaD
Apixaban—CYP2C8—brain—brain cancer	6.73e-05	0.0109	CbGeAlD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	6.67e-05	0.00105	CbGpPWpGaD
Apixaban—ABCG2—brain—brain cancer	6.55e-05	0.0106	CbGeAlD
Apixaban—CYP3A4—endocrine gland—brain cancer	6.37e-05	0.0103	CbGeAlD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.29e-05	0.00099	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.2e-05	0.000976	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ENO2—brain cancer	6.02e-05	0.000947	CbGpPWpGaD
Apixaban—ABCB1—gonad—brain cancer	5.97e-05	0.00965	CbGeAlD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.84e-05	0.000919	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	5.83e-05	0.000918	CbGpPWpGaD
Apixaban—ABCB1—pituitary gland—brain cancer	5.82e-05	0.00941	CbGeAlD
Apixaban—CYP3A4—central nervous system—brain cancer	5.74e-05	0.00928	CbGeAlD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.66e-05	0.000892	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.63e-05	0.000886	CbGpPWpGaD
Apixaban—ABCB1—medulla oblongata—brain cancer	5.62e-05	0.00908	CbGeAlD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	5.27e-05	0.00083	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.21e-05	0.00082	CbGpPWpGaD
Apixaban—ABCB1—midbrain—brain cancer	5.14e-05	0.0083	CbGeAlD
Apixaban—ABCB1—spinal cord—brain cancer	5.01e-05	0.0081	CbGeAlD
Apixaban—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.98e-05	0.000784	CbGpPWpGaD
Apixaban—F10—Hemostasis—IL2—brain cancer	4.87e-05	0.000766	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.81e-05	0.000758	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.62e-05	0.000728	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL2—brain cancer	4.6e-05	0.000725	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.53e-05	0.000714	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	4.52e-05	0.000711	CbGpPWpGaD
Apixaban—ABCB1—endocrine gland—brain cancer	4.51e-05	0.00729	CbGeAlD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.48e-05	0.000705	CbGpPWpGaD
Apixaban—ABCB1—head—brain cancer	4.45e-05	0.0072	CbGeAlD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.43e-05	0.000697	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.33e-05	0.000682	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.33e-05	0.000682	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.27e-05	0.000672	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP2C9—brain cancer	4.19e-05	0.000659	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	4.16e-05	0.000655	CbGpPWpGaD
Apixaban—F10—Hemostasis—VEGFA—brain cancer	4.14e-05	0.000651	CbGpPWpGaD
Apixaban—ABCB1—central nervous system—brain cancer	4.07e-05	0.00657	CbGeAlD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.06e-05	0.000639	CbGpPWpGaD
Apixaban—ABCB1—cerebellum—brain cancer	3.97e-05	0.00642	CbGeAlD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.97e-05	0.000624	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.91e-05	0.000616	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.81e-05	0.000599	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CTNNB1—brain cancer	3.7e-05	0.000582	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—BSG—brain cancer	3.56e-05	0.000561	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.47e-05	0.000547	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.43e-05	0.00054	CbGpPWpGaD
Apixaban—ABCB1—brain—brain cancer	3.23e-05	0.00522	CbGeAlD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.23e-05	0.000508	CbGpPWpGaD
Apixaban—F10—Hemostasis—TP53—brain cancer	3.12e-05	0.000492	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—IDH1—brain cancer	3.06e-05	0.000482	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP2C9—brain cancer	3e-05	0.000472	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.97e-05	0.000467	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CG—brain cancer	2.76e-05	0.000434	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.69e-05	0.000424	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP2C9—brain cancer	2.6e-05	0.000409	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—BSG—brain cancer	2.55e-05	0.000402	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.51e-05	0.000395	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ENO2—brain cancer	2.42e-05	0.000381	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP2C9—brain cancer	2.32e-05	0.000365	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP2C9—brain cancer	2.26e-05	0.000356	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.21e-05	0.000349	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—BSG—brain cancer	2.21e-05	0.000348	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—IDH1—brain cancer	2.19e-05	0.000345	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.19e-05	0.000345	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—BSG—brain cancer	1.97e-05	0.00031	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.93e-05	0.000304	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—BSG—brain cancer	1.93e-05	0.000303	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—IDH1—brain cancer	1.9e-05	0.000299	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2C9—brain cancer	1.81e-05	0.000285	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—BSG—brain cancer	1.8e-05	0.000283	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.78e-05	0.00028	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.74e-05	0.000273	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ENO2—brain cancer	1.73e-05	0.000273	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—IDH1—brain cancer	1.7e-05	0.000267	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—IDH1—brain cancer	1.66e-05	0.000261	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.55e-05	0.000244	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—IDH1—brain cancer	1.55e-05	0.000243	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—BSG—brain cancer	1.54e-05	0.000242	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ENO2—brain cancer	1.5e-05	0.000236	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.46e-05	0.00023	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2C9—brain cancer	1.39e-05	0.00022	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.38e-05	0.000217	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ENO2—brain cancer	1.34e-05	0.000211	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—IDH1—brain cancer	1.32e-05	0.000208	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ENO2—brain cancer	1.31e-05	0.000206	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.26e-05	0.000198	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ENO2—brain cancer	1.22e-05	0.000192	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BSG—brain cancer	1.19e-05	0.000187	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CG—brain cancer	1.11e-05	0.000175	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.08e-05	0.000169	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ENO2—brain cancer	1.04e-05	0.000164	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—IDH1—brain cancer	1.02e-05	0.000161	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ENO2—brain cancer	8.06e-06	0.000127	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CG—brain cancer	7.96e-06	0.000125	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CG—brain cancer	6.89e-06	0.000108	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CG—brain cancer	6.15e-06	9.68e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CG—brain cancer	6e-06	9.45e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CG—brain cancer	5.61e-06	8.83e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CG—brain cancer	4.79e-06	7.54e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CG—brain cancer	3.7e-06	5.82e-05	CbGpPWpGaD
